Estriol
(Synonyms: 雌三醇; Oestriol) 目录号 : GC12182
Estriol是雌激素受体（ERα和ERβ）的激动剂和G蛋白偶联受体30（GPR30）的拮抗剂。
Cas No.:50-27-1
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Estriol is an agonist of estrogen receptors (ERα and ERβ) and G protein-coupled receptor 30 (GPR30) antagonist [1]. Estriol binds to ERα/ERβ in the nucleus, inducing gene transcription and influencing cell proliferation, differentiation, and other functions [2]. Estriol is used for topical skin anti-aging and potential immunomodulatory treatments [3-4].
In SkBr3 cells, Estriol (1μM; 6d) can block the abnormal proliferation of breast cancer cells by inhibiting the GPR30-dependent signaling pathway [1]. In MDA-MB-231 cells, Estriol (1-80μM; 7d) inhibits 17β-estradiol-stimulated cell proliferation [5]. In myelin basic protein-reactive T cell, Estriol (0-50ng/mL; 16h) treatment showed a dose-dependent inhibitory effect on cell migration [6].
In pentylenetetrazol (PTZ)-kindled epilepsy mouse model, Estriol (0.005mg/kg, 0.01mg/kg; ip; single injection) treatment increases the incidence of epileptic seizures [7]. In a streptozotocin-induced type 1 diabetic mouse model, Estriol (3.5µM; iv; single injection) controls hyperglycemia through hepatic insulin synthesis [8].
References:
[1]. Lappano R, Rosano C, De Marco P, et al. Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells[J]. Molecular and cellular endocrinology, 2010, 320(1-2): 162-170.
[2]. Kim S, Liva S M, Dalal M A, et al. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis[J]. Neurology, 1999, 52(6): 1230-1230.
[3]. Ali E S, Mangold C, Peiris A N. Estriol: emerging clinical benefits[J]. Menopause, 2017, 24(9): 1081-1085.
[4]. Merrill R C. Estriol: a review[J]. Physiological reviews, 1958, 38(3): 463-480.
[5]. Girgert R, Emons G, Gründker C. Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol[J]. BMC cancer, 2014, 14(1): 935.
[6]. Zang Y C Q, Halder J B, Hong J, et al. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-κB[J]. Journal of neuroimmunology, 2002, 124(1-2): 106-114.
[7]. Ahmad A, Vohora D. Proconvulsant effects of estriol, the third estrogen, in the mouse PTZ-kindling model[J]. Neurological Sciences, 2014, 35(10): 1561-1566.
[8]. Bhattacharya S, Bank S, Maiti S, et al. The control of hyperglycemia by estriol and progesterone in alloxan induced type I diabetes mellitus mice model through hepatic insulin synthesis[J]. International Journal of Biomedical Science: IJBS, 2014, 10(1): 8.
Estriol是雌激素受体（ERα和ERβ）的激动剂和G蛋白偶联受体30（GPR30）的拮抗剂 [1]。Estriol在细胞核内与ERα/ERβ结合，诱导基因转录并影响细胞增殖、分化等功能 [2]。Estriol用于局部皮肤抗衰老和潜在的免疫调节治疗 [3-4]。
在SkBr3细胞中，Estriol（1μM；6d）可通过抑制GPR30依赖性信号通路来阻断乳腺癌细胞的异常增殖 [1]。在MDA-MB-231细胞中，Estriol（1-80μM；7d）可抑制17β-雌二醇刺激的细胞增殖 [5]。在髓鞘碱性蛋白反应性T细胞中，Estriol（0-50ng/mL；16h）处理显示出剂量依赖性的细胞迁移抑制作用 [6]。
在戊四氮（PTZ）点燃的癫痫小鼠模型中，Estriol（0.005mg/kg，0.01mg/kg;ip；单次注射）治疗可增加癫痫发作的发生率 [7]。在链脲佐菌素诱发的1型糖尿病小鼠模型中，Estriol（3.5µM；iv；单次注射）通过肝脏胰岛素合成控制高血糖 [8]。
| Cell experiment [1]: | |
Cell lines | SkBr3 cells |
Preparation Method | SkBr3 breast cancer cells were seeded in 96-well plates at a density of 10,000 cells per well. After adherence, they were cultured in 2.5% delipidated FBS and treated with the GPR30 agonist G-1 (100nM) and/or Estriol (E3, 1μM). Incubation was continued for 6 days, with fresh medium and treatment every 2 days. After treatment, cell proliferation activity was assessed using the MTT assay. |
Reaction Conditions | 1μM; 6d |
Applications | Estriol can block the abnormal proliferation of breast cancer cells by inhibiting the GPR30-dependent signaling pathway. |
| Animal experiment [2]: | |
Animal models | Pentylenetetrazol (PTZ)-kindled epilepsy mouse model |
Preparation Method | Swiss Albino mice weighing between 25 and 35g were used. They were housed in polypropylene cages and maintained at 25–30℃ and 50–55 % humidity in a natural light/dark cycle. Estriol was dissolved in DMSO and administered in doses of 0.005 and 0.01mg/kg, ip. Control group received DMSO as vehicle. Clomiphene was dissolved in distilled water and administered intraperitoneally at dose of 0.9mg/kg. Diazepam was taken as standard and was given at 3mg/kg. Pentylenetetrazole (PTZ) was administered 1h after Estriol and clomiphene treatment and 1.5h after diazepam treatment in the respective groups. |
Dosage form | 0.005mg/kg, 0.01mg/kg; ip; single injection |
Applications | Estriol treatment increases the incidence of epileptic seizures in mice. |
References: | |
| Cas No. | 50-27-1 | SDF | |
| 别名 | 雌三醇; Oestriol | ||
| 化学名 | (8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol | ||
| Canonical SMILES | CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O | ||
| 分子式 | C18H24O3 | 分子量 | 288.39 |
| 溶解度 | ≥ 9.25mg/mL in DMSO | 储存条件 | Store at RT |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.4675 mL | 17.3376 mL | 34.6753 mL |
| 5 mM | 0.6935 mL | 3.4675 mL | 6.9351 mL |
| 10 mM | 0.3468 mL | 1.7338 mL | 3.4675 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet